Login to Your Account

NewCo News

Dutalys Gets First Taker for Bispecific Antibody Platform

By Cormac Sheridan
Staff Writer

Wednesday, December 19, 2012
Dutalys GmbH, an early stage company developing a bispecific antibody platform, entered a research collaboration with a top 10 pharmaceutical firm that could evolve into a product licensing alliance.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription